Immune checkpoint inhibitors plus chemotherapy in first-line endometrial cancer treatment: Still the era of microsatellites?

CONCLUSIONS: Adding ICIs to chemotherapy significantly improves PFS in first-line endometrial cancer, regardless of MMR status.PMID:38164107 | DOI:10.1111/1471-0528.17749

Source: BJOG : An International Journal of Obstetrics and Gynaecology - January 2, 2024 Category: OBGYN Authors: Mauro Francesco Pio Maiorano Carlo Messina Evaristo Maiello Gennaro Cormio Brigida Anna Maiorano Source Type: research